ID
33888
Beskrivning
Study ID:103860/269 Clinical Study ID:103860/269 (HBV-269) Study Title: Phase II study to evaluate the immunogenicity of GSK Biologicals' preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™-B and evaluate safety and reactogenicity of each vaccine when administered intramuscularly according to a 0, 1, 6 month schedule in healthy volunteers Patient Level Data:Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B
Nyckelord
Versioner (1)
- 2019-01-05 2019-01-05 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
5 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Immunogenicity, safety and reactogenicity of preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™️-B
Visit 5
- StudyEvent: ODM
Beskrivning
Laboratory Tests
Alias
- UMLS CUI-1
- C0022885
Beskrivning
Collection of blood specimen for laboratory procedure
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0005834
Beskrivning
Collection of blood specimen for laboratory procedure, Antibodies
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0005834
- UMLS CUI [1,2]
- C0003241
Similar models
Visit 5
- StudyEvent: ODM
C0003241 (UMLS CUI [1,2])